Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Free Cash Flow (2020 - 2025)

Treace Medical Concepts' Free Cash Flow history spans 6 years, with the latest figure at -$10.4 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 43.17% year-over-year to -$10.4 million; the TTM value through Dec 2025 reached -$29.5 million, up 39.53%, while the annual FY2025 figure was -$29.5 million, 39.53% up from the prior year.
  • Free Cash Flow reached -$10.4 million in Q4 2025 per TMCI's latest filing, up from -$11.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $655000.0 in Q1 2025 to a low of -$18.7 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$9.5 million, with a median of -$10.3 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: plummeted 1363.42% in 2022, then skyrocketed 105.88% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$4.7 million in 2021, then crashed by 63.86% to -$7.7 million in 2022, then skyrocketed by 77.69% to -$1.7 million in 2023, then crashed by 324.3% to -$7.3 million in 2024, then plummeted by 43.17% to -$10.4 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Free Cash Flow are -$10.4 million (Q4 2025), -$11.9 million (Q3 2025), and -$7.8 million (Q2 2025).